Xenobiotic-responsive hepatic long non-coding RNAs
Xenobiotic-responsive hepatic long non-coding RNAs
批准号:
10809269
负责人:
DAVID J WAXMAN
金额:
$7.78万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-15 至 2025-04-30
关键词:
AbbreviationsAddressAdultAffectAgonistArchitectureAutomobile DrivingBenzeneBiologicalCRISPR interferenceCellsChemical ExposureChemicalsChromatinChromatin LoopCirrhosisClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexDeoxyribonucleasesDependovirusDevelopmentDiagnosisDietDiseaseDisease ProgressionEnvironmentEnvironmental PollutantsEnzymesEpigenetic ProcessEtiologyEvaluationEventExposure toFatty LiverGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranscriptionGenomeGenomicsGuide RNAHealthHepaticHepatic lobuleHepatocyteHigh Fat DietHumanIndustrializationInflammationKnock-outLigandsLinkLiverLiver CirrhosisLiver FailureLiver diseasesLobuleMediatorMetabolic PathwayMetabolismMitochondriaModelingMusNuclearNuclear Pore ComplexNuclear ReceptorsOrthologous GenePPAR alphaPathologicPathologyPathway AnalysisPathway interactionsPhysiological ProcessesPositioning AttributePrimary carcinoma of the liver cellsProcessProteinsReceptor ActivationRegulator GenesResearchRoleSerotypingSiteSpecificityTestingTimeTissuesUntranslated RNAWorkXenobiotic MetabolismXenobioticsadvanced diseaseblood glucose regulationcarbohydrate metabolismcell typeconstitutive androstane receptorendonucleaseenvironmental chemicalenvironmental chemical exposurefatty liver diseasegene networkgene regulatory networkgene repressionin vivoinsightinterestlipid biosynthesislipid metabolismliver developmentliver metabolismmouse modelnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel markerpregnane X receptorpreventprogramspromoterprototypereceptorsingle nucleus RNA-sequencingtherapeutic targettranscription factortranscription terminationtranscriptometranscriptomic profiling
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. Project Summary/Abstract
Many industrial chemicals, environmental pollutants and other xenochemicals activate transcription factors
belonging to the nuclear receptor superfamily, which leads to widespread genomic, epigenetic and
transcriptional changes that disrupt key biological pathways and metabolic processes in liver and other
tissues. The studies proposed focus on the liver nuclear receptor CAR (Constitutive Androstane Receptor;
NR1I3), which is activated by structurally diverse xenochemicals and regulates transcription of hundreds of
protein-coding genes important for processes such as xenobiotic metabolism, lipogenesis, glucose
homeostasis, and inflammation, and has been implicated as a regulator of non-alcoholic fatty liver disease
(NAFLD) development. We have discovered that xenobiotic agonists of CAR and other xenobiotic-responsive
receptors induce or repress the transcription of several hundred nuclear-enriched long non-coding RNAs
(lncRNAs) with epigenetic and gene regulatory potential, many of which have human orthologs. This proposal
builds on these findings and on recent advances in liver cell zonation, single cell-based transcriptomic
profiling, and gene co-expression network analysis to elucidate in an intact mouse liver model the effects of
CAR-responsive lncRNAs on fatty liver disease induced by foreign chemical exposure. The studies proposed
test the hypothesis that a subset of CAR-responsive lncRNAs control hepatic gene regulatory networks driving
NAFLD and downstream pathologies, dysregulating processes such as lipid and carbohydrate metabolism,
hepatic architecture and mitochondrial function in a liver cell type-specific and hepatic lobule zone-dependent
manner. The work proposed uses TCPOBOP (1,4-bis[2-(3,5-dichloro-pyridyloxy)]benzene), a prototypic non-
genotoxic chemical and CAR-specific agonist ligand, to address the seemingly paradoxical finding that
persistent exposure to foreign chemical CAR activators induces NAFLD in mice fed normal chow diet, but
suppresses NAFLD development in mice fed a high fat diet. These studies will elucidate the role of CAR, and
the lncRNAs that it regulates, in fatty liver disease etiology and progression. Results obtained will give critical
insight into the underlying mechanisms by which foreign chemicals dysregulate CAR-dependent metabolic
pathways linked to NAFLD, which affects 25% of US adults and is a major cause of cirrhosis, hepatocellular
cancer and liver failure. This work will refocus research efforts on xenochemical action to include mechanistic
studies of single cell-based, spatially zonated gene regulatory networks and the non-coding transcriptome,
and will serve as a paradigm for other foreign chemical-activated receptors that dysregulate gene expression
in complex ways. Together, the proposed studies on CAR-responsive lncRNAs and their role in xenochemical-
induced liver pathology may lead to new ways to prevent, diagnose or treat liver diseases induced by chemical
exposure.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0150284
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Oshida K, Waxman DJ, Corton JC]
通讯作者:
Corton JC
Impact of Neonatal Activation of Nuclear Receptor CAR (Nr1i3) on Cyp2 Gene Expression in Adult Mouse Liver.
新生儿核受体 CAR (Nr1i3) 激活对成年小鼠肝脏 Cyp2 基因表达的影响。
DOI:
10.1093/toxsci/kfac032
发表时间:
2022
期刊:
Toxicological sciences : an official journal of the Society of Toxicology
影响因子:
--
作者:
[Shin,Aram, Waxman,DavidJ]
通讯作者:
Waxman,DavidJ
DOI:
10.1016/j.mce.2022.111722
发表时间:
2022-11-01
期刊:
MOLECULAR AND CELLULAR ENDOCRINOLOGY
影响因子:
4.1
作者:
[Kim, Donghwan, Kim, Bora, Brocker, Chad N., Karri, Kritika, Waxman, David J., Gonzalez, Frank J.]
通讯作者:
Gonzalez, Frank J.
DOI:
10.1186/s12864-021-07478-5
发表时间:
2021-03-24
期刊:
BMC genomics
影响因子:
4.4
作者:
[Goldfarb CN, Waxman DJ]
通讯作者:
Waxman DJ
DOI:
10.1038/s41467-020-19554-7
发表时间:
2020-11-17
期刊:
Nature communications
影响因子:
16.6
作者:
[Brocker CN, Kim D, Melia T, Karri K, Velenosi TJ, Takahashi S, Aibara D, Bonzo JA, Levi M, Waxman DJ, Gonzalez FJ]
通讯作者:
Gonzalez FJ
共 7 条
Xenobiotic-responsive hepatic long non-coding RNAs
-
批准号:10711162
-
项目类别:
-
资助金额:$3.49万
-
财政年份:2022
-
负责人:DAVID J WAXMAN
-
依托单位:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
-
批准号:9897015
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2019
-
负责人:DAVID J WAXMAN
-
依托单位:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
-
批准号:10626011
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2019
-
负责人:DAVID J WAXMAN
-
依托单位:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
-
批准号:10402862
-
项目类别:
-
资助金额:$49.5万
-
财政年份:2019
-
负责人:DAVID J WAXMAN
-
依托单位:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
-
批准号:10164773
-
项目类别:
-
资助金额:$49.37万
-
财政年份:2019
-
负责人:DAVID J WAXMAN
-
依托单位:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
-
批准号:10018890
-
项目类别:
-
资助金额:$50.31万
-
财政年份:2019
-
负责人:DAVID J WAXMAN
-
依托单位:
Epigenetic Actions of Environmental Chemicals
-
批准号:8762618
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2014
-
负责人:DAVID J WAXMAN
-
依托单位:
Xenobiotic-responsive hepatic long non-coding RNAs
-
批准号:10615645
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2014
-
负责人:DAVID J WAXMAN
-
依托单位:
Xenobiotic-responsive hepatic long non-coding RNAs
-
批准号:10394387
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2014
-
负责人:DAVID J WAXMAN
-
依托单位:
Xenobiotic-responsive hepatic long non-coding RNAs
-
批准号:10210396
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2014
-
负责人:DAVID J WAXMAN
-
依托单位:
Xenobiotic-responsive hepatic long non-coding RNAs
-
批准号:10058507
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2014
-
负责人:DAVID J WAXMAN
-
依托单位:
Cytochrome P450-Endogenous Substrate Metabolism
-
批准号:8037913
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:DAVID J WAXMAN
-
依托单位:
Epigenetic Marks of Xenoestrogen Exposure
-
批准号:7941819
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2009
-
负责人:DAVID J WAXMAN
-
依托单位:
Cytochrome P450-Endogenous Substrate Metabolism
-
批准号:7992597
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2009
-
负责人:DAVID J WAXMAN
-
依托单位:
Epigenetic Marks of Xenoestrogen Exposure
-
批准号:8077724
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2009
-
负责人:DAVID J WAXMAN
-
依托单位:
Epigenetic Marks of Xenoestrogen Exposure
-
批准号:7830420
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2009
-
负责人:DAVID J WAXMAN
-
依托单位:
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals
-
批准号:6901352
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2005
-
负责人:DAVID J WAXMAN
-
依托单位:
PPAR, hormones, and xenobiotics
-
批准号:6664578
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2002
-
负责人:DAVID J WAXMAN
-
依托单位:
PPAR, hormones, and xenobiotics
-
批准号:6578802
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2002
-
负责人:DAVID J WAXMAN
-
依托单位:
PPAR, hormones, and xenobiotics
-
批准号:6443953
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2001
-
负责人:DAVID J WAXMAN
-
依托单位:
海外基金